ABSI — Absci Corp
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1672688 ·
Last close
$10.60
Market Cap
$1.80B
52W High
$12.06
52W Low
$2.92
ADV30
7,380,482
Next earnings
2026-05-07
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 215,000 | — | -30,846,000 | -29,599,000 | 195,593,000 | 8,627,000 | 23,622,000 |
| Dec 2025 | 650,000 | — | -36,142,000 | -29,562,000 | 216,297,000 | 20,025,000 | 26,848,000 |
| Sep 2025 | 378,000 | — | -30,154,000 | -28,706,000 | 244,992,000 | 9,476,000 | 34,652,000 |
| Jun 2025 | 593,000 | — | -31,393,000 | -30,569,000 | 209,892,000 | 38,024,000 | 36,519,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-92,925,000
Investing CF
$-50,160,000
Financing CF
$105,949,000
CapEx
$-1,233,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.85
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-624,784,000
Inventory
—
Receivables
$1,000,000
ST Investments
$124,267,000
EBIT TTM
$-114,905,000
Pretax Income TTM
$-115,114,000
Interest Exp TTM
$209,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,836,000
EBITDA
$-116,437,000
Free Cash Flow
$-41,475,376
Enterprise Value
$1,666,941,056
Total Cash
$125,705,000
Total Debt
$4,415,000
Shares Out
169,400,333
Trailing EPS
$-0.82
Book Value
$1.11
ROE
-63.9%
ROA
-37.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,800,000 | -125,418,000 | -115,183,000 | 216,297,000 | 26,848,000 | — | -92,925,000 |
| Dec 2024 | 4,534,000 | -108,888,000 | -103,106,000 | 213,608,000 | 34,475,000 | — | -72,402,000 |
| Dec 2023 | 5,718,000 | -94,180,000 | -110,566,000 | 217,298,000 | 41,122,000 | — | -64,636,000 |
| Dec 2022 | 5,747,000 | -106,750,000 | -104,904,000 | 321,008,000 | 46,594,000 | — | -81,339,000 |
TTM Snapshot
Revenues TTM
$1,701,000
NetIncome TTM
$-27,398,000
OpCashFlow TTM
$0
Assets (Latest)
$213,608,000
Forward EPS
$-0.62
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | $1.99B | $14.22 | — |
| NEOG | NEOGEN CORP | $2.09B | $9.62 | — |
| QDEL | QuidelOrtho Corp | $1.25B | $18.27 | — |
| CLDX | Celldex Therapeutics, Inc. | $3.07B | $39.11 | — |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | $627.25M | $6.11 | — |
News headlines (Yahoo Finance, 1h cache)
Here's Why Absci Corporation (ABSI) is a Great Momentum Stock to Buy
2026-07-02 16:00 · Yahoo
Absci Raises $100 Million In Equity To Fund AI-Designed Hair Loss And Endometriosis Program
2026-06-27 10:01 · Yahoo
Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy
2026-06-26 10:27 · Yahoo
Absci (ABSI) Is Up 37.8% After ABS-201 Data And Equity Raise - Has The Bull Case Changed?
2026-06-26 08:06 · Yahoo
ABSI Soars 36% on Positive Interim Update From Phase I Hair Loss Study
2026-06-25 14:21 · Yahoo
ABSCI CORP (ABSI) Soars 36.0%: Is Further Upside Left in the Stock?
2026-06-25 10:18 · Yahoo
Why Did UAL, GLW, ABSI Stocks Surge To 52-Week Highs Today?
2026-06-25 03:24 · Yahoo
ABSI Stock Eyes Best Day Ever After Positive Hair Loss Drug Data, $100M Lilly-Backed Raise
2026-06-24 19:55 · Yahoo
Absci Shares Soar After Positive Early Clinical Results for Hair Loss Therapy (ABSI)
2026-06-24 12:59 · Yahoo
Absci, FuelCell Energy surge premarket; Cerebras, FedEx tumble
2026-06-24 12:07 · Yahoo
Recent Insider Activity
| Filed | Trade | Insider | Title | Type | Price | Qty | Value |
|---|---|---|---|---|---|---|---|
| 2026-07-06 16:06:13 | 2026-06-30 | Szela Mary T | Dir | P - Purchase | 11.54 | 12900 | 148866 |